Status:
COMPLETED
Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches
Lead Sponsor:
University of Toledo Health Science Campus
Conditions:
Migraine
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, si...
Detailed Description
This study will evaluate the efficacy of the Fisher Wallace Cranial Stimulator in persons with chronic migraine who have not achieved satisfactory pain control on their current medications.
Eligibility Criteria
Inclusion
- Subjects satisfying the IHS (International Headache Society) criteria for migraine
- Subjects have not achieved satisfactory pain control on their current medication
- Ability to maintain a daily headache diary
- Stable medication use related to migraine for at least 4 weeks prior to enrollment in the study
Exclusion
- Previous exposure to or experience with cranial electrotherapy stimulation (CES)
- Contraindications to Fisher Wallace stimulator, such as cardiac pacemakers or implantable defibrillators, known or suspected heart disease, or pregnancy
- Seizure disorders
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01265797
Start Date
December 1 2011
End Date
July 1 2013
Last Update
February 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Toledo, Health Science Campus
Toledo, Ohio, United States, 43614